Massive Genomics Competitors and Similar CompaniesClear all

Massive Genomics's competitors and similar companies include Cellaria, Annoroad Gene Technology, Veronomics and Oncomine Molecular.
Massive Genomics
Massive Genomics
Massive Genomics is a company that provides genomic analysis services.
Cellaria
Cellaria
Cellaria is a company creating next generation in vitro disease models that reflect the nature of a patient’s biology.
Annoroad Gene Technology
Annoroad Gene Technology
Annoroad Gene Technology is a company that develops genomic technologies for research and clinical market.
Veronomics
Veronomics
Veronomics is a company developing a series of VeroTests in order to match drug susceptibilities to specific cancers.
Oncomine Molecular
Oncomine Molecular
Oncomine Molecular is a provider of next-generation sequencing (NGS) and genomic profiling for advancing cancer research and cancer patient outcomes.
Founding Date
Founding Date
2016
Founding Date
2013
Founding Date
2012
Founding Date
2018
Founding Date
2018
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Nairobi, KE HQ
Locations
Boxford, US HQ
Wakefield, US
Locations
CN HQ
Locations
HQ
Locations
Waltham, US HQ
Employees
Employees
1
Employees
3
Employees
28
Employees
1
Employees
6
For sources of this data, please see the company profile

View Company Profiles

Cellaria
HQ
Boxford, US
Employees
3

Cellaria is a company creating next generation in vitro disease models that reflect the nature of a patient’s biology.

View company
Annoroad Gene Technology
HQ
CN
Employees
28

Annoroad Gene Technology is a company that develops genomic technologies for research and clinical market.

View company
Veronomics
HQ
Employees
1

Veronomics is a company developing a series of VeroTests in order to match drug susceptibilities to specific cancers.

View company
Oncomine Molecular
HQ
Waltham, US

Oncomine Molecular is a provider of next-generation sequencing (NGS) and genomic profiling for advancing cancer research and cancer patient outcomes.

View company